Answers are grounded in this paper and cite their sources.
Editorials1 August 1985Does Central Nervous System Adaptation to Antecedent Glycemia Occur in Patients with Insulin-Dependent Diabetes Mellitus?PHILIP E. CRYER, M.D.PHILIP E. CRYER, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-103-2-284 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptGlucose derived from the circulation is the predominant metabolic fuel used by the central nervous system under most physiologic conditions. Hypoglycemia causes brain dysfunction (neuroglycopenia) and can cause brain death, because it deprives the central nervous system neurons of this critical fuel. Thus, it is not surprising that effective glucose counterregulatory mechanisms evolved. Indeed, in all persons except those who use drugs that lower the plasma glucose concentration, hypoglycemia is an unusual clinical event.The prevention or correction of hypoglycemia is normally the result of both dissipation of insulin and activation of glucose counterregulatory systems (1, 2). Insulin suppresses hepatic...References1. CRYERTSECLUTTERSHAH PTWS. The roles of glucagon and epinephrine in hypoglycemic and nonhypoglycemic glucose counterregulation in man. Am J Physiol. 1984;247(2 pt 1):E198-E205. MedlineGoogle Scholar2. CRYERGERICH PJ. Glucose counterregulation, hypoglycemia and intensive insulin therapy of diabetes mellitus. N Engl J Med. (in press.) Google Scholar3. DEFEOVENTURAPERRIELLODECOSMOBRUNETTI PMGSP. Counterregulatory role of growth hormone and cortisol in prolonged hypoglycemia [Abstract]. Diabetes. 1985;34(suppl 1):100A. Google Scholar4. BOLLIDEFEOPERRIELLO GPG. Role of hepatic autoregulation in defense against hypoglycemia in humans. J Clin Invest. 1985;75:1623-31. CrossrefMedlineGoogle Scholar5. ASPLINRAGHUKOERKERPALMER CPDJ. Glucose counter-regulation during recovery from neuroglycopenia: which mechanism is important? Metabolism 1985;34:15-8. CrossrefMedlineGoogle Scholar6. WHITESKORCRYERLEVANDOSKIBIERSANTIAGO NDPLDJ. Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med. 1983;308:485-91. CrossrefMedlineGoogle Scholar7. SANTIAGOWHITESKORLEVANDOSKIBIERCRYER JNDLDP. Defective glucose counterregulation limits the intensive therapy of diabetes mellitus. Am J Physiol. 1984;247(2 pt l):E215-20. MedlineGoogle Scholar8. WHITEGINGERICHCRYERSANTIAGO NRPJ. Plasma pancreatic polypeptide response to insulin induced hypoglycemia as a marker for defective glucose counterregulation is insulin dependent diabetes mellitus. Diabetes. (In press). Google Scholar9. BOLLIDEFEODECOSMO GPS. A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus. Diabetes. 1984;33:732-7. CrossrefMedlineGoogle Scholar10. HOELDTKEBODENSHUMANOWEN RGCO. Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomic neuropathy. Ann Intern Med. 1982;96:459-62. LinkGoogle Scholar11. THORSTEINSSONPRAMMINGLAURITZENBINDER BSTC. Frequency of biochemical hypoglycaemia at different blood glucose levels in conventionally and pump treated type I (insulin dependent) diabetic patients [Abstract]. Diabetologia. 1984;27:338A. Google Scholar12. ARIASKERNERZIERNAVASCUESPFEIFFER PWHIE. Incidence of hypoglycemic episodes in diabetic patients under continuous subcutaneous insulin infusion and intensified conventional insulin treatment: assessment by means of semiambulatory 24-hour continuous blood glucose monitoring. Diabetes Care. 1985;8:134-40. CrossrefMedlineGoogle Scholar13. ENSINCKKANTER JR. Glucagon responses to hypoglycemia in type I diabetic men after 24-hour glucoregulation by glucose-controlled insulin infusion. Diabetes Care. 1980;3:285-9. CrossrefMedlineGoogle Scholar14. BERGENSTALPOLONSKYPONSJASPANRUBENSTEIN RKGJA. Lack of glucagon response to hypoglycemia in type I diabetics after long-term optimal therapy with a continuous subcutaneous insulin infusion pump. Diabetes. 1983;32:398-402. CrossrefMedlineGoogle Scholar15. BOLLIDEFEODECOSMO GPS. Effects of long-term optimization and short-term deterioration of glycemic control on glucose counterregulation in type I diabetes mellitus. Diabetes. 1984;33:394-400. CrossrefMedlineGoogle Scholar16. SIMONSONTAMBORLANEDEFRONZOSHERWIN DWRR. Intensive insulin therapy reduces counterregulatory hormone responses to hypoglycemia in patients with type I diabetes. Ann Intern Med. 1985;103:184-90. LinkGoogle Scholar17. LAGERBLOHMEVON SCHENCKSMITH IGHU. Importance of glucose control for the recovery from hypoglycemia in insulin-dependent diabetics. Diabetes. 1982;31:771-5. CrossrefMedlineGoogle Scholar18. GJEDDECRONE AC. Blood-brain glucose transfer: repression in chronic hyperglycemia. Science. 1981;214:456-7. CrossrefMedlineGoogle Scholar19. MCCALLMILLINGTONWURTMAN AWR. Metabolic fuel and amino acid transport into the brain in experimental diabetes mellitus. Proc Natl Acad Sci USA. 1982;79:5406-10. CrossrefMedlineGoogle Scholar20. MCCALLTORNHEIMFLEMINGRUDERMAN AKNN. Brain transport and metabolism in chronic hypoglycemia [Abstract]. Diabetes. 1985;34(suppl 1):37A. MedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Washington University School of Medicine St. Louis, Missouri PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByClassical Conditioning of Insulin Effects in Healthy HumansBrain Glucose Uptake and Unawareness of Hypoglycemia in Patients with Insulin-Dependent Diabetes MellitusRecovery of hypoglycaemia-associated compromised cerebral function after a short interval of euglycaemia in insulin-dependent diabetic patientsEffects of previous glycaemic control on the onset and magnitude of cognitive dysfunction during hypoglycaemia in Type 1 (insulin-dependent) diabetic patientsEffect of pancreas transplantation on glucose counterregulation in insulin-dependent diabetic patients prone to severe hypoglycaemiaSubstrate availability other than glucose in the brain during euglycemia and insulin-induced hypoglycemia in dogsRecent Advances in Carbohydrate Nutrition and Metabolism in Diabetes MellitusHome blood glucose monitoring — a reviewNeuropeptides and Glucose MetabolismHypoglycemia in diabetes among children and adolescentsCounterregulatory hormonal responses to hypoglycaemia in Type 1 (insulin-dependent) diabetes: evidence for diminished hypothalamic-pituitary hormonal secretionPlasma Glucose Concentrations at the Onset of Hypoglycemic Symptoms in Patients with Poorly Controlled Diabetes and in NondiabeticsAntecedent chronic hyperglycaemia blocks phlorizin-induced insulin resistance in the dogLe risque hypoglycémique chez les diabétiques insulinodépendants ou pourquoi les DID perçoivent-ils souvent mal les symptômes d'alerte de l'hypoglycémie?Home Blood Glucose Monitoring: Keystone for Modern Diabetes CareHypoglycaemia and DiabetesHome Monitoring of Diabetes Mellitus—A Quiet RevolutionHypoglycemia in the Critically Ill Patient 1 August 1985Volume 103, Issue 2Page: 284-286KeywordsBlood plasmaBrainCentral nervous systemDiabetes mellitusDrugsGlucoseHypoglycemiaInsulinMedical servicesNeurons Issue Published: 1 August 1985 PDF DownloadLoading ...
No takes yet. Share an insight, caveat, or question.
Philip E. Cryer (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: